Evolent Health Stock (NYSE:EVH)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$11.18

52W Range

$10.53 - $35.00

50D Avg

$17.24

200D Avg

$24.16

Market Cap

$1.33B

Avg Vol (3M)

$2.60M

Beta

1.59

Div Yield

-

EVH Company Profile


Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

4,700

IPO Date

Jun 05, 2015

Website

EVH Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Evolent Health Services Segment$1.96B$407.50M-
Clinical Solutions Segment-$944.51M-
Platforms And Operations Services--$896.75M
Transformation Services--$11.20M

Fiscal year ends in Dec 23 | Currency in USD

EVH Financial Summary


Dec 23Dec 22Dec 21
Revenue$1.96B$1.35B$907.96M
Operating Income$35.23B$-59.84M$30.25M
Net Income$-142.26M$-18.70M$-30.28M
EBITDA$35.33B$7.36M$90.28M
Basic EPS$-1.28$-0.20$-0.35
Diluted EPS$-1.28$-0.20$-0.35

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Nov 09, 24 | 9:12 AM
Q2 24Aug 08, 24 | 9:18 PM
Q1 24May 09, 24 | 12:00 AM

Peer Comparison


TickerCompany
FORAForian Inc.
NRCNational Research Corporation
DHDefinitive Healthcare Corp.
PRVAPrivia Health Group, Inc.
SLPSimulations Plus, Inc.
HQYHealthEquity, Inc.
CERTCertara, Inc.
HCATHealth Catalyst, Inc.
CMAXCareMax, Inc.